Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short-course alendronate to prevent ART-associated bone loss in antiretroviral-naive adults with HIV-1
2014-004819-37Phase 4Completed
- Sponsor
- University College Dublin
- Start
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in human immunodeficiency virus infection (HIV) comparing Fostolin plus calcium and vitamin D with ART initiation with Placebo plus calcium and vitamin D with ART initiation (2 arms). Primary endpoint: Between-group difference in percentage change in total hip bone mineral density. Started Feb 2015; status: completed.
02
Drugs
alendronate
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2014-004819-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004819-37.